<p>, /PRNewswire/ --</p>
<p>原因：羅森律師事務所是一家全球投資者權益律師事務所，提醒在 2024 年 8 月 7 日至 2025 年 2 月 24 日期間（包括這兩個日期）購買 Maravai Lifesciences Holdings, Inc.（納斯達克代碼：MRVI）證券的投資者注意 2025 年 5 月 5 日的重要首席原告截止日期。</p>
<p>那麼，<strong>：</strong> 如果您在該期間購買了 Maravai 證券，您可能有權在不支付任何自付費用或成本的情況下，通過風險代理安排獲得賠償。</p>
<p>接下來該做什麼：要加入 Maravai 集體訴訟，請訪問 https://rosenlegal.com/submit-form/?case_id=36259 或撥打無障礙電話 866-767-3653 聯繫 Phillip Kim 律師，或發送電子郵件至 [email protected] 獲取有關集體訴訟的信息。集體訴訟已經提起。如果您希望擔任首席原告，必須在 2025 年 5 月 5 日之前向法院提出申請。首席原告是代表其他集體成員在訴訟中行事的代表方。</p>
<p>為什麼選擇羅森律師事務所：我們鼓勵投資者選擇在領導角色中有成功記錄的合格律師事務所。通常，發佈通知的律師事務所沒有可比的經驗、資源或任何有意義的同行認可。這些律師事務所中的許多實際上並不進行證券集體訴訟，而只是作為中介，轉介客户或與實際進行案件訴訟的律師事務所合作。在選擇律師時要明智。羅森律師事務所代表全球投資者，專注於證券集體訴訟和股東衍生訴訟。羅森律師事務所曾在當時獲得針對一家中國公司的最大證券集體訴訟和解。2017 年，羅森律師事務所被 ISS 證券集體訴訟服務評為證券集體訴訟和解數量第一。自 2013 年以來，該事務所每年均排名前四，併為投資者追回了數億美元。僅在 2019 年，該事務所就為投資者爭取了超過 4.38 億美元。2020 年，創始合夥人 Laurence Rosen 被 law360 評選為原告律師界的巨頭。該事務所的許多律師已獲得 Lawdragon 和 Super Lawyers 的認可。</p>
<p>案件詳情：根據訴訟，在該期間，被告作出了虛假和/或誤導性的陳述，和/或未能披露以下內容：（1）Maravai 在與收入確認相關的財務報告方面缺乏足夠的內部控制；（2）因此，Maravai 在 2024 財年對某些交易的收入確認不準確；（3）其商譽被高估；（4）因此，被告對 Maravai 的業務、運營和前景的積極陳述在實質上具有誤導性和/或缺乏合理依據。</p>
<p>要加入 Maravai 集體訴訟，請訪問 https://rosenlegal.com/submit-form/?case_id=36259 或撥打無障礙電話 866-767-3653 聯繫 Phillip Kim 律師，或發送電子郵件至 [email protected] 獲取有關集體訴訟的信息。集體訴訟已經提起。</p>
<p>尚未認證集體。直到集體被認證，您不會被律師代表，除非您聘請一位。您可以選擇您自己的律師。您也可以選擇保持缺席集體成員身份，此時不採取任何行動。投資者分享任何潛在未來賠償的能力並不依賴於擔任首席原告。</p>
<p>請關注我們的 LinkedIn 更新：https://www.linkedin.com/company/the-rosen-law-firm，Twitter：https://twitter.com/rosen_firm 或 Facebook：https://www.facebook.com/rosenlawfirm/。</p>
<p>律師廣告。先前的結果並不保證類似的結果。</p>
<p>聯繫信息：</p>
<p>Laurence Rosen 律師。</p>
<p>Phillip Kim 律師。</p>
<p>羅森律師事務所，P.A.。</p>
<p>275 Madison Avenue, 40th Floor</p>
<p>紐約，NY 10016</p>
<p>電話：（212）686-1060</p>
<p>免費電話：（866）767-3653</p>
<p>傳真：（212）202-3827</p>
<p>[email protected]</p>
<p>www.rosenlegal.com</p>
<p>來源：羅森律師事務所，P.A.。</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzMxJk5ld3NJdGVtSWQ9REM1Mzk5NCZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMzExODQzUFJfTkVXU19VU1BSX19fX19EQzUzOTk0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzMxJk5ld3NJdGVtSWQ9REM1Mzk5NCZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMzExODQzUFJfTkVXU19VU1BSX19fX19EQzUzOTk0"/></p>

MRVI

<p>羅森律師事務所提醒在 2024 年 8 月 7 日至 2025 年 2 月 24 日期間購買了 Maravai Lifesciences Holdings, Inc.（納斯達克代碼：MRVI）證券的投資者，集體訴訟的主要原告截止日期為 2025 年 5 月 5 日。該訴訟指控 Maravai 在其財務報告和收入確認方面做出了誤導性陳述。投資者可以在沒有前期費用的情況下加入集體訴訟。欲瞭解更多信息，請聯繫 Phillip Kim 律師，電話：866-767-3653 或通過電子郵件聯繫</p>

<p>, /PRNewswire/ --</p>
<div class="lb-trans"><p>, /PRNewswire/ --</p>
</div><p>Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025, both dates inclusive (the &#34;Class Period&#34;), of the important May 5, 2025 lead plaintiff deadline.</p>
<div class="lb-trans"><p>原因：羅森律師事務所是一家全球投資者權益律師事務所，提醒在 2024 年 8 月 7 日至 2025 年 2 月 24 日期間（包括這兩個日期）購買 Maravai Lifesciences Holdings, Inc.（納斯達克代碼：MRVI）證券的投資者注意 2025 年 5 月 5 日的重要首席原告截止日期。</p>
</div><p>So what <strong>:</strong> If you purchased Maravai securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.</p>
<div class="lb-trans"><p>那麼，<strong>：</strong> 如果您在該期間購買了 Maravai 證券，您可能有權在不支付任何自付費用或成本的情況下，通過風險代理安排獲得賠償。</p>
</div><p>What to do next: To join the Maravai class action, go to https://rosenlegal.com/submit-form/?case_id=36259 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 5, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.</p>
<div class="lb-trans"><p>接下來該做什麼：要加入 Maravai 集體訴訟，請訪問 https://rosenlegal.com/submit-form/?case_id=36259 或撥打無障礙電話 866-767-3653 聯繫 Phillip Kim 律師，或發送電子郵件至 [email protected] 獲取有關集體訴訟的信息。集體訴訟已經提起。如果您希望擔任首席原告，必須在 2025 年 5 月 5 日之前向法院提出申請。首席原告是代表其他集體成員在訴訟中行事的代表方。</p>
</div><p>Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.</p>
<div class="lb-trans"><p>為什麼選擇羅森律師事務所：我們鼓勵投資者選擇在領導角色中有成功記錄的合格律師事務所。通常，發佈通知的律師事務所沒有可比的經驗、資源或任何有意義的同行認可。這些律師事務所中的許多實際上並不進行證券集體訴訟，而只是作為中介，轉介客户或與實際進行案件訴訟的律師事務所合作。在選擇律師時要明智。羅森律師事務所代表全球投資者，專注於證券集體訴訟和股東衍生訴訟。羅森律師事務所曾在當時獲得針對一家中國公司的最大證券集體訴訟和解。2017 年，羅森律師事務所被 ISS 證券集體訴訟服務評為證券集體訴訟和解數量第一。自 2013 年以來，該事務所每年均排名前四，併為投資者追回了數億美元。僅在 2019 年，該事務所就為投資者爭取了超過 4.38 億美元。2020 年，創始合夥人 Laurence Rosen 被 law360 評選為原告律師界的巨頭。該事務所的許多律師已獲得 Lawdragon 和 Super Lawyers 的認可。</p>
</div><p>Details of the case: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Maravai lacked adequate internal controls over financial reporting related to revenue recognition; (2) as a result, Maravai inaccurately recognized revenue on certain transactions during fiscal 2024; (3) its goodwill was overstated; and (4) as a result of the foregoing, defendants' positive statements about Maravai's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.</p>
<div class="lb-trans"><p>案件詳情：根據訴訟，在該期間，被告作出了虛假和/或誤導性的陳述，和/或未能披露以下內容：（1）Maravai 在與收入確認相關的財務報告方面缺乏足夠的內部控制；（2）因此，Maravai 在 2024 財年對某些交易的收入確認不準確；（3）其商譽被高估；（4）因此，被告對 Maravai 的業務、運營和前景的積極陳述在實質上具有誤導性和/或缺乏合理依據。</p>
</div><p>To join the Maravai class action, go to https://rosenlegal.com/submit-form/?case_id=36259 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed.</p>
<div class="lb-trans"><p>要加入 Maravai 集體訴訟，請訪問 https://rosenlegal.com/submit-form/?case_id=36259 或撥打無障礙電話 866-767-3653 聯繫 Phillip Kim 律師，或發送電子郵件至 [email protected] 獲取有關集體訴訟的信息。集體訴訟已經提起。</p>
</div><p>No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.</p>
<div class="lb-trans"><p>尚未認證集體。直到集體被認證，您不會被律師代表，除非您聘請一位。您可以選擇您自己的律師。您也可以選擇保持缺席集體成員身份，此時不採取任何行動。投資者分享任何潛在未來賠償的能力並不依賴於擔任首席原告。</p>
</div><p>Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.</p>
<div class="lb-trans"><p>請關注我們的 LinkedIn 更新：https://www.linkedin.com/company/the-rosen-law-firm，Twitter：https://twitter.com/rosen_firm 或 Facebook：https://www.facebook.com/rosenlawfirm/。</p>
</div><p>Attorney Advertising. Prior results do not guarantee a similar outcome.</p>
<div class="lb-trans"><p>律師廣告。先前的結果並不保證類似的結果。</p>
</div><p>Contact Information:</p>
<div class="lb-trans"><p>聯繫信息：</p>
</div><p>Laurence Rosen, Esq.</p>
<div class="lb-trans"><p>Laurence Rosen 律師。</p>
</div><p>Phillip Kim, Esq.</p>
<div class="lb-trans"><p>Phillip Kim 律師。</p>
</div><p>The Rosen Law Firm, P.A.</p>
<div class="lb-trans"><p>羅森律師事務所，P.A.。</p>
</div><p>275 Madison Avenue, 40th Floor</p>
<div class="lb-trans"><p>275 Madison Avenue, 40th Floor</p>
</div><p>New York, NY 10016</p>
<div class="lb-trans"><p>紐約，NY 10016</p>
</div><p>Tel: (212) 686-1060</p>
<div class="lb-trans"><p>電話：（212）686-1060</p>
</div><p>Toll Free: (866) 767-3653</p>
<div class="lb-trans"><p>免費電話：（866）767-3653</p>
</div><p>Fax: (212) 202-3827</p>
<div class="lb-trans"><p>傳真：（212）202-3827</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>www.rosenlegal.com</p>
<div class="lb-trans"><p>www.rosenlegal.com</p>
</div><p>SOURCE THE ROSEN LAW FIRM, P. A.</p>
<div class="lb-trans"><p>來源：羅森律師事務所，P.A.。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzMxJk5ld3NJdGVtSWQ9REM1Mzk5NCZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMzExODQzUFJfTkVXU19VU1BSX19fX19EQzUzOTk0" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC53994&amp;Transmission_Id=202503311843PR_NEWS_USPR_____DC53994&amp;DateId=20250331"/></p>

MRVI 投資者有機會主導 Maravai Lifesciences Holdings, Inc.的證券欺詐訴訟